We live in capitalist economies that deliver great wealth, innovation and dynamism but lurch from systemic crisis to crisis, throw up gigantic inequalities and are careless about nature and the societies of which they are part. Its obvious that we want more of the former and less of the latter but how? Never easy, this question is now so bitterly dividing western politics that in the US there is even talk of a second civil war. Post-Brexit Britain is only fractionally less toxic.
There are two increasingly hostile camps living in their intellectual and political silos. On the one hand, there are the me firsts, the apostles of salvation through individualism. Capitalism propelled by individuals aggressively pursuing their own self-interest will deliver the goods. It is essentially self-organising, self-propelling and self-dynamic. Dont worry about booms, busts, monopoly and disastrous social side-effects; we have to put up with them as we do with the weather. They will sort themselves out in time. Any public intervention will bring errors and costs that outweigh the benefits. Allow the tall poppies to grow even taller and wealth will ultimately trickle down; inequality is the price paid for capitalist effectiveness. Capitalism harnesses the base metals of human greed and self-interest to deliver the alchemy of economic dynamism.
On the other hand, are the we firsts. They are equally passionate in their insistence that salvation lies in the group and society and convinced, whether on the climate emergency, hi-tech monopolies, crippling uncertainties about living standards or just the evident truth that we humans are altruists as much as individualists, that to follow the me firsts is the road to perdition. What is crucial to us as social beings is the group, society, the commonweal and belonging as equals. After all, it was associating in groups that was fundamental to our evolutionary capacity to hunt and to see off predators. That primeval urge to associate in the group is what underpins happiness and wellbeing. What people want is less the exercise of choice in markets, more to control their lives in the service of what they value and that is best done collectively and, as far as possible, equitably.
And so the Is and wes confront each other in intense enmity, crystallised in the debates about the proper reaction to the virus. The Is inhabit a world in which we must make our own choices, even over vaccination, and the state must be minimalist. The wes urge mandatory vaccination, early lockdowns and Covid passports. Yet the sustainable policy is to blend the two: to find ways of persuading individuals, by choice and shaming, to get vaccinated and to ensure that Covid passports are employed, but only when it is clear that public health demands it for NHS and care workers and for any large events. Too much we zeal and there is insupportable state intrusion into our lives; too much I libertarianism and you are free to infect and maybe kill me. Yes, we need the pluralism of different options and individual agency; equally, we need an agile public realm and collective action to serve the group.
The good society (and successful public policy) is one that cleverly uses its institutions to reconcile the we with the I. It is great institutions, in the private and public sectors, which bind society and mitigate the worst excesses of both group force and individual licence. The problem is that we have too few of them and those we do have are being undermined by the dominance of the me firsts who insist anything to do with the we is coercive and undermines liberty.
Thus, despite the me firsts, we witness the success of the NHS through this pandemic, plainly dedicated to serve the we but never in such a way as to be oppressive. Thus, too, the amazing vaccines incubated in Oxfords Jenner Institute, the university itself an example of combining the we of a shared academic vocation but with 37 individual, competing colleges. These were then rolled out with the impetus of the Cell and Gene Therapy Catapult, an institution part tax-funded and part funded from its own commercial activities but one consecrated to promoting the public interest of a strong cell and gene ecology. And all further enabled by an enlightened capitalist enterprise, AstraZeneca, which institutionally recognised its social purpose of promoting health by selling a billion doses at cost.
Another institution that has proved its worth in the pandemic is the BBC, particularly its political and health teams. Laura Kuenssberg and Ros Atkins, for example, have shown the power of impartiality, while Fergus Walsh and Hugh Pym have been models of rock-solid, informed reporting. It has had a cascade effect on much of the media. In a deadly pandemic, beyond some on the Conservative backbenches and rightwing columnists, there can be no luxuriating in ideology. Everyone wants to get to the other side in the best and safest way they can.
Our democratic institutions have been less secure. The checks and balances vital to political integrity have been found wanting. It should never have been possible for the prime minister to use executive discretion, backed by a parliamentary majority, retrospectively to change the terms of the committee on standards in public life; it should be understood that these institutions, including the Electoral Commission, can be reformed only deliberatively and with cross-party support. They represent the we. Public procurement, too, has proved spectacularlyopen to abuse. Meanwhile, the Tory party has demonstrated its institutional weakness, becoming hostage to its ultra-libertarian wing and arriving at public health policies erratically and often too late.
The wider lesson is clear. If we want the best of capitalism and less of the worst, we need to build institutions across our economy, society and democracy that covenant through their constitutions, from a company to a university, that they will respect values we hold dear: equality, fairness, universality, transparency, societal obligation and sustainability. Indeed, in the face of 21st-century challenges AI, the drive to net zero, levelling up great institutions are more important than ever. They will not emerge spontaneously from markets and the operation of capitalism. They have to be created and sustained, the progressive project of the decades ahead.
Will Hutton is an Observer columnist. His December lecture to the Academy of Social Sciences, Its institutions stupid the moralisation of capitalism, from which this column is drawn, is available here
Read more:
Which philosophy helps us confront the crises that beset us... we first or me first? - The Guardian
- About the Gene Therapy Review - November 8th, 2009 [November 8th, 2009]
- Contribute an Article - November 8th, 2009 [November 8th, 2009]
- EBSCO Publishing Deal - November 8th, 2009 [November 8th, 2009]
- Advertising Opportunities - November 8th, 2009 [November 8th, 2009]
- Instructions for Authors - November 8th, 2009 [November 8th, 2009]
- Isis Collaboration With Ortho-McNeil Inc for Metabolic Diseases - November 8th, 2009 [November 8th, 2009]
- Dystrophin Gene Transfer safe in Duchenne muscular dystrophy - November 8th, 2009 [November 8th, 2009]
- Researchers Identify Gene for Rare Form of Spinal Muscular Atrophy - November 8th, 2009 [November 8th, 2009]
- Fatal brain cancer tamed by New gene therapy - November 8th, 2009 [November 8th, 2009]
- Gene therapy effective in fighting obesity in mice - November 8th, 2009 [November 8th, 2009]
- Genzyme gene therapy for people with peripheral artery disease failed in a clinical trial to help them regain some mobility - November 8th, 2009 [November 8th, 2009]
- Gene Therapy May Stall Inherited Emphysema - December 31st, 2009 [December 31st, 2009]
- Gene Therapy and Stem Cells Save Limb - December 31st, 2009 [December 31st, 2009]
- TNVitamins.com – $10 Off Of $50 order - May 7th, 2011 [May 7th, 2011]
- 15% Off Any PetAlive Order - May 7th, 2011 [May 7th, 2011]
- At PetAlive – $10 off order of $50 or more - May 7th, 2011 [May 7th, 2011]
- Native Remedies coupon – 5% Off Any Order - May 7th, 2011 [May 7th, 2011]
- Native Remedies – Save $5 coupon - May 7th, 2011 [May 7th, 2011]
- Welcome to the Gene Therapy Review - May 15th, 2011 [May 15th, 2011]
- Editorial Board - May 15th, 2011 [May 15th, 2011]
- Gene Therapy Job Board - May 15th, 2011 [May 15th, 2011]
- Corporate Membership - May 22nd, 2011 [May 22nd, 2011]
- Native Remedies coupon – 25% Off Any Order - May 29th, 2011 [May 29th, 2011]
- What is Gene Therapy? - June 19th, 2011 [June 19th, 2011]
- Research and Markets: Recent Advances in Cancer Research and Therapy - Increased Research on one of the Major Causes ... - April 25th, 2012 [April 25th, 2012]
- Gene Therapy part 2 - Video - April 30th, 2012 [April 30th, 2012]
- Gene therapy reverses Parkinson's symptoms: study - Video - April 30th, 2012 [April 30th, 2012]
- CBS This Morning - Gene therapy reverses Parkinson's symptoms: study - Video - April 30th, 2012 [April 30th, 2012]
- Engineering adenoviruses for gene therapy - Video - April 30th, 2012 [April 30th, 2012]
- What is Gene Therapy (The General Explains) - Video - April 30th, 2012 [April 30th, 2012]
- What is Gene Therapy - Animation - Video - April 30th, 2012 [April 30th, 2012]
- Microbiology Gene Therapy - Video - April 30th, 2012 [April 30th, 2012]
- Gene Therapy in Detail - Video - April 30th, 2012 [April 30th, 2012]
- Breakthrough in Haemophilia treatment - Video - April 30th, 2012 [April 30th, 2012]
- Virology Seminar - Gene Therapy - April 30th, 2012 [April 30th, 2012]
- Gene Therapy Video - Video - April 30th, 2012 [April 30th, 2012]
- Study: Gene Therapy for HIV Safe, But Effectiveness Still Unclear - May 4th, 2012 [May 4th, 2012]
- Gene Therapy Safe in Decade-Long HIV Study That May Widen Use - May 4th, 2012 [May 4th, 2012]
- Gene therapy for HIV safe, but effectiveness still unclear - May 4th, 2012 [May 4th, 2012]
- A Step Forward For Gene Therapy To Treat HIV - May 4th, 2012 [May 4th, 2012]
- A Media Event on Clinical Developments in Gene and Cell Therapy - May 4th, 2012 [May 4th, 2012]
- Families of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophy - May 4th, 2012 [May 4th, 2012]
- AIDS gene therapy safe -- is it a "cure"? - May 4th, 2012 [May 4th, 2012]
- Generational Achievements in Gene and Cell Therapy Honored at ASGCT 15th Annual Meeting - May 5th, 2012 [May 5th, 2012]
- Lewis speaks on gene therapy at Lexington Community Education event - May 7th, 2012 [May 7th, 2012]
- Penn researchers report a gene-therapy success - May 10th, 2012 [May 10th, 2012]
- Gene therapy for hearing loss: Potential and limitations - May 13th, 2012 [May 13th, 2012]
- Gene therapy extends mouse lifespan by 24 pc - May 16th, 2012 [May 16th, 2012]
- Gene therapy dramatically extends mouse lifespan - May 16th, 2012 [May 16th, 2012]
- Gene therapy may extend life: Study - May 16th, 2012 [May 16th, 2012]
- First gene therapy successful against aging-associated decline: Mouse lifespan extended up to 24% with a single ... - May 16th, 2012 [May 16th, 2012]
- Gene Therapy Extends Mouse Lifespan - May 16th, 2012 [May 16th, 2012]
- Gene Therapy for Brain Disease - May 17th, 2012 [May 17th, 2012]
- Children with rare, incurable brain disease improve after gene therapy - May 17th, 2012 [May 17th, 2012]
- FIRST Anti-Aging Gene Therapy (Brainstorm Ep72) - Video - May 23rd, 2012 [May 23rd, 2012]
- Gene therapy can correct forms of severe combined immunodeficiency - May 25th, 2012 [May 25th, 2012]
- RetroSense Therapeutics Completes pre-IND Meeting for RST-001 - May 25th, 2012 [May 25th, 2012]
- Gene therapy can correct forms of severe combined immunodeficiency, study suggests - May 26th, 2012 [May 26th, 2012]
- Alliance for Cancer Gene Therapy celebrates 10 years - May 29th, 2012 [May 29th, 2012]
- Research on gene therapy by Prasad Eye - June 1st, 2012 [June 1st, 2012]
- Baxter Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment - June 5th, 2012 [June 5th, 2012]
- Transgenomic Launches Breakthrough Blood-Based Cancer Gene Testing Technology at 2012 ASCO Annual Meeting - June 5th, 2012 [June 5th, 2012]
- Baxter Inks Deal with Chatham - June 6th, 2012 [June 6th, 2012]
- PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued – Exclusively Licensed to Transgenomic - June 11th, 2012 [June 11th, 2012]
- SalutarisMD Announces Positive Case Report of a New Investigational Wet AMD Therapy at ARVO - June 15th, 2012 [June 15th, 2012]
- Research and Markets: Gene Therapy - Global Strategic Business Report - 2012 - June 15th, 2012 [June 15th, 2012]
- New York Law Firm’s MesotheliomaHelp.net Site Publishes Interview with Gene Therapy Author - June 17th, 2012 [June 17th, 2012]
- uniQure Extends Collaboration with Protein Sciences Corporation on Use of its expresSF+® Cell Line for Gene Therapy - June 19th, 2012 [June 19th, 2012]
- Anti-cocaine vaccine described in Human Gene Therapy Journal - June 19th, 2012 [June 19th, 2012]
- bluebird bio Receives U.S. and European Orphan Drug Designation for Novel Gene Therapy to Treat Adrenoleukodystrophy - June 19th, 2012 [June 19th, 2012]
- Close to a cure: Greater Hartford takes on rare Jewish genetic disease - June 19th, 2012 [June 19th, 2012]
- Gene Therapy Helps Treat Children with Rare Brain Disorder - June 20th, 2012 [June 20th, 2012]
- Gold nanoparticles capable of 'unzipping' DNA - June 21st, 2012 [June 21st, 2012]
- ‘Gene-silencing’ drug can halt and reverse deadly brain disorder - June 21st, 2012 [June 21st, 2012]
- uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinson's Disease - June 22nd, 2012 [June 22nd, 2012]
- Gene-silencing method offers possible therapy for Huntington's disease - June 22nd, 2012 [June 22nd, 2012]
- Gene mutations cause massive brain asymmetry - June 24th, 2012 [June 24th, 2012]
- Research and Markets: Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features ... - June 25th, 2012 [June 25th, 2012]
- Stress Blocks Gene That Guards Brain Against Depression - June 26th, 2012 [June 26th, 2012]
- Targeted gene therapy enhances treatment for Pompe disease - June 26th, 2012 [June 26th, 2012]